Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 2
1995 2
1996 4
1997 3
2000 1
2001 2
2002 1
2003 1
2004 1
2005 1
2006 1
2007 3
2008 3
2009 5
2010 12
2011 14
2012 17
2013 17
2014 15
2015 22
2016 20
2017 21
2018 17
2019 16
2020 18
2021 17
2022 15
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

210 results

Results by year

Filters applied: . Clear all
Page 1
Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis.
Bieber T, Simpson EL, Silverberg JI, Thaçi D, Paul C, Pink AE, Kataoka Y, Chu CY, DiBonaventura M, Rojo R, Antinew J, Ionita I, Sinclair R, Forman S, Zdybski J, Biswas P, Malhotra B, Zhang F, Valdez H; JADE COMPARE Investigators. Bieber T, et al. N Engl J Med. 2021 Mar 25;384(12):1101-1112. doi: 10.1056/NEJMoa2019380. N Engl J Med. 2021. PMID: 33761207 Clinical Trial.
Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo.
Rosmarin D, Passeron T, Pandya AG, Grimes P, Harris JE, Desai SR, Lebwohl M, Ruer-Mulard M, Seneschal J, Wolkerstorfer A, Kornacki D, Sun K, Butler K, Ezzedine K; TRuE-V Study Group. Rosmarin D, et al. N Engl J Med. 2022 Oct 20;387(16):1445-1455. doi: 10.1056/NEJMoa2118828. N Engl J Med. 2022. PMID: 36260792
Practical management of acne for clinicians: An international consensus from the Global Alliance to Improve Outcomes in Acne.
Thiboutot DM, Dréno B, Abanmi A, Alexis AF, Araviiskaia E, Barona Cabal MI, Bettoli V, Casintahan F, Chow S, da Costa A, El Ouazzani T, Goh CL, Gollnick HPM, Gomez M, Hayashi N, Herane MI, Honeyman J, Kang S, Kemeny L, Kubba R, Lambert J, Layton AM, Leyden JJ, López-Estebaranz JL, Noppakun N, Ochsendorf F, Oprica C, Orozco B, Perez M, Piquero-Martin J, See JA, Suh DH, Tan J, Lozada VT, Troielli P, Xiang LF. Thiboutot DM, et al. Among authors: lopez estebaranz jl. J Am Acad Dermatol. 2018 Feb;78(2 Suppl 1):S1-S23.e1. doi: 10.1016/j.jaad.2017.09.078. Epub 2017 Nov 8. J Am Acad Dermatol. 2018. PMID: 29127053 Review.
Consensus-Based Acne Classification System and Treatment Algorithm for Spain.
López-Estebaranz JL, Herranz-Pinto P, Dréno B; el grupo de dermatólogos expertos en acné. López-Estebaranz JL, et al. Actas Dermosifiliogr. 2017 Mar;108(2):120-131. doi: 10.1016/j.ad.2016.10.001. Epub 2016 Nov 3. Actas Dermosifiliogr. 2017. PMID: 27816123 Free article. English, Spanish.
Pathogenesis, Clinical Signs and Treatment Recommendations in Brittle Nails: A Review.
Chessa MA, Iorizzo M, Richert B, López-Estebaranz JL, Rigopoulos D, Tosti A, Gupta AK, Di Chiacchio N, Di Chiacchio NG, Rubin AI, Baran R, Lipner SR, Daniel R, Chiheb S, Grover C, Starace M, Piraccini BM. Chessa MA, et al. Among authors: lopez estebaranz jl. Dermatol Ther (Heidelb). 2020 Feb;10(1):15-27. doi: 10.1007/s13555-019-00338-x. Epub 2019 Nov 20. Dermatol Ther (Heidelb). 2020. PMID: 31749091 Free PMC article. Review.
European evidence-based (S3) guideline for the treatment of acne - update 2016 - short version.
Nast A, Dréno B, Bettoli V, Bukvic Mokos Z, Degitz K, Dressler C, Finlay AY, Haedersdal M, Lambert J, Layton A, Lomholt HB, López-Estebaranz JL, Ochsendorf F, Oprica C, Rosumeck S, Simonart T, Werner RN, Gollnick H. Nast A, et al. Among authors: lopez estebaranz jl. J Eur Acad Dermatol Venereol. 2016 Aug;30(8):1261-8. doi: 10.1111/jdv.13776. J Eur Acad Dermatol Venereol. 2016. PMID: 27514932 No abstract available.
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials.
Griffiths CE, Reich K, Lebwohl M, van de Kerkhof P, Paul C, Menter A, Cameron GS, Erickson J, Zhang L, Secrest RJ, Ball S, Braun DK, Osuntokun OO, Heffernan MP, Nickoloff BJ, Papp K; UNCOVER-2 and UNCOVER-3 investigators. Griffiths CE, et al. Lancet. 2015 Aug 8;386(9993):541-51. doi: 10.1016/S0140-6736(15)60125-8. Epub 2015 Jun 10. Lancet. 2015. PMID: 26072109 Clinical Trial.
Arthritis during dupilumab therapy.
García-Zamora E, Gómez de la Fuente E, López-Estebaranz JL. García-Zamora E, et al. Among authors: lopez estebaranz jl. Med Clin (Barc). 2023 Oct 27;161(8):365-366. doi: 10.1016/j.medcli.2023.05.020. Epub 2023 Jul 6. Med Clin (Barc). 2023. PMID: 37422369 English, Spanish. No abstract available.
Hypertrichosis and blisters in an infant.
Sarró-Fuente C, Martín-Alcalde J, Pampín-Franco A, Palencia-Pérez SI, López-Estebaranz JL. Sarró-Fuente C, et al. Among authors: lopez estebaranz jl. Pediatr Dermatol. 2021 May;38(3):688-690. doi: 10.1111/pde.14574. Pediatr Dermatol. 2021. PMID: 34224613 No abstract available.
High-risk cutaneous squamous cell carcinoma.
Nuño-González A, Vicente-Martín FJ, Pinedo-Moraleda F, López-Estebaranz JL. Nuño-González A, et al. Among authors: lopez estebaranz jl. Actas Dermosifiliogr. 2012 Sep;103(7):567-78. doi: 10.1016/j.ad.2011.09.005. Epub 2012 Jan 17. Actas Dermosifiliogr. 2012. PMID: 22261673 Free article. Review. English, Spanish.
210 results